Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-26-026457

Options or other derivatives

  • Interim CEO & General Counsel acquired 235,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2026-03-09 Grant or award · Restricted Stock Units +235,000 235,000 D: show line 1 in the form
Loading xslF345X05/tm268453-6_4seq1.xml…